[{"id":5410,"regimens":[{"id":10076,"duration":null,"drug":{"id":8782,"name":"Lopinavir","url":"cure-api2.ncats.io/v1/drugs/8782","rxNorm_id":null,"notes":null},"use_drug":[{"id":5862,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":10076},{"id":5863,"answer":"In a novel combination with another drug","answer_other":"","regimen":10076}],"created":"2020-04-30T01:37:58.674606Z","updated":"2020-05-06T00:20:19.091728Z","dose":null,"frequency":"","route":"","severity":"Inpatient","severity_detail":null,"comments":null,"report":5410},{"id":10077,"duration":null,"drug":{"id":10164,"name":"Ritonavir","url":"cure-api2.ncats.io/v1/drugs/10164","rxNorm_id":null,"notes":null},"use_drug":[{"id":5864,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":10077},{"id":5865,"answer":"In a novel combination with another drug","answer_other":"","regimen":10077}],"created":"2020-04-30T01:37:58.680424Z","updated":"2020-05-06T00:20:19.088960Z","dose":null,"frequency":"","route":"","severity":"Inpatient","severity_detail":null,"comments":null,"report":5410},{"id":10078,"duration":null,"drug":{"id":8462,"name":"Interferon Alfa-2B","url":"cure-api2.ncats.io/v1/drugs/8462","rxNorm_id":null,"notes":null},"use_drug":[{"id":5866,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":10078},{"id":5867,"answer":"In a novel combination with another drug","answer_other":"","regimen":10078}],"created":"2020-04-30T01:37:58.686518Z","updated":"2020-05-06T00:20:19.086213Z","dose":"5, 000, 000 IU","frequency":"BD","route":"Aerosol inhalation","severity":"Inpatient","severity_detail":null,"comments":null,"report":5410}],"site_of_infection":[],"specific_site":[],"how_outcome":[{"id":7111,"answer":"PCR","answer_other":"","report":5410},{"id":7112,"answer":"Imaging","answer_other":"","report":5410},{"id":7113,"answer":"Clinical assessment","answer_other":"","report":5410}],"how_diagnosis":[{"id":11774,"answer":"PCR","answer_other":"","report":5410},{"id":11869,"answer":"Imaging","answer_other":"","report":5410},{"id":11870,"answer":"Clinical assessment","answer_other":"","report":5410}],"author_username":"CURE ID Admin","resistant_drugs":[],"combo_drugs":[],"organisms":[{"id":1892,"name":"Coronavirus - covid-19"}],"disease_name":"COVID-19","author_qualification":"Medical Doctor","author_affiliation":"FDA/NCATS","author_country":"United States","outcome_computed":"Improved","previous_drugs":[],"comments":[],"article_language":"English","why_new_way":[{"id":3227,"answer":"There is no standard/approved therapy for this disease","answer_other":"","report":5410},{"id":3274,"answer":"Unusual disease presentation","answer_other":"","report":5410}],"adverse_event_outcome":[],"is_author":false,"cross_linked_diseases":[{"id":399,"name":"Diarrhea (Infectious)"}],"races":[],"created":"2020-04-30T01:37:58.661382Z","updated":"2020-05-01T20:04:19.938016Z","title":"SARS-CoV-2 induced diarrhoea as onset symptom in patient with COVID-19.","status":"Approved","anonymous":false,"published":true,"pubmed_id":32139552,"doi":"10.1136/gutjnl-2020-320891","article_url":"https://www.ncbi.nlm.nih.gov/pubmed/?term=32139552","pub_year":2020,"published_authors":"Song Y, Liu P, Shi XL, Chu YL, Zhang J, Xia J, Gao XZ, Qu T, Wang MY","article_author_email":"","journal":"Gut","abstract":"On 29 January 2020, a 22-year-old man presented himself to the local fever clinic, with a 4-day history of diarrhoea and low-grade fever. The highest temperature was 38.3°C, and diarrhoea was about 3–4 times a day. No other abnormalities were observed. He took two kinds of Chinese patent medicines for gastrointestinal discomfort for 3 days while the symptoms were not significantly improved. Regular stool examination and bacterial cultures showed negative results for common pathogens. Lung auscultation revealed rhonchi, and chest radiography was performed, showing pneumonia in the bilateral lungs (see figure 1). He confessed that he had a history of short stay in Wuhan on 22 January. Considering his travel history, a clinical diagnosis of suspected COVID-19 was made and the local health departments were immediately notified.","article_type":"","study_type":"Case Report","number_of_patients":1,"article_patient_number":"","full_text_available":false,"outcome":"Patient improved","surgery":"","age":"21-30 years","sex":"Male","ethnicity":null,"country_contracted":"China","country_treated":"China","began_treatment_year":"2020","hiv":false,"asthma":false,"lung_disease":false,"diabetes_mellitus":false,"hypertension":false,"cardiovascular_disease":false,"chronic_renal_disease":false,"chronic_liver_disease":false,"immunosuppressant_drugs":false,"intellectual_disability":false,"smoker":false,"other_immunodeficiency":false,"other_comorbid":"NR","pregnant":false,"unknown":false,"site_of_disease":"","clinical_syndrome":"Fever and diarrhea","severity":"Inpatient","prev_treatment":"","unusual":"","drug_treatment_features":"","have_adverse_events":false,"adverse_events":"","when_outcome":"","follow_up_period":null,"relapse":"","reminder":true,"when_reminder":"2 weeks","additional_info":"Ever on mechanical ventilation (invasive or non-invasive)?: N\r\nAuthor defined severe?: NR\r\nJustification for author-indicated response: \"After antiviral treatments, the diarrhoea of the patient was ameliorated and then disappeared completely\"\r\nDay in disease course that symptoms were noted to begin improving: NR\r\nDay in disease course that full resolution of symptoms was noted: NR\r\nDay in disease course that patient was discharged if admitted: NR\r\nJustification for timing of resolution: \"On 16 February, nucleic acid detection of SARS-CoV-2 turned negative, and CT scan result showed that the inflammation was significantly decreased in the bilateral lungs. Now he fully recovered and was discharged home\"","previously_treated":"","flagged":false,"other_coinfections":"","disease":630,"drugs":[8462,8782,10164]},{"id":5446,"regimens":[{"id":10184,"duration":null,"drug":{"id":8782,"name":"Lopinavir","url":"cure-api2.ncats.io/v1/drugs/8782","rxNorm_id":null,"notes":null},"use_drug":[{"id":5980,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":10184}],"created":"2020-04-30T01:39:35.541152Z","updated":"2020-05-06T00:20:19.312412Z","dose":null,"frequency":"","route":"","severity":"ICU/Critical Care","severity_detail":null,"comments":null,"report":5446},{"id":10185,"duration":null,"drug":{"id":10164,"name":"Ritonavir","url":"cure-api2.ncats.io/v1/drugs/10164","rxNorm_id":null,"notes":null},"use_drug":[{"id":5981,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":10185}],"created":"2020-04-30T01:39:35.546550Z","updated":"2020-05-06T00:20:19.309646Z","dose":null,"frequency":"","route":"","severity":"ICU/Critical Care","severity_detail":null,"comments":null,"report":5446},{"id":10187,"duration":null,"drug":{"id":9197,"name":"Moxifloxacin","url":"cure-api2.ncats.io/v1/drugs/9197","rxNorm_id":null,"notes":null},"use_drug":[{"id":5982,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":10187}],"created":"2020-04-30T01:39:35.557638Z","updated":"2020-05-06T00:20:19.306962Z","dose":null,"frequency":"","route":"IV","severity":"ICU/Critical Care","severity_detail":null,"comments":null,"report":5446},{"id":10230,"duration":null,"drug":{"id":11311,"name":"Interferon Alfa","url":"cure-api2.ncats.io/v1/drugs/11311","rxNorm_id":null,"notes":null},"use_drug":[{"id":5984,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":10230}],"created":"2020-05-05T13:29:54.341884Z","updated":"2020-05-06T00:20:19.345999Z","dose":null,"frequency":"","route":"inhalation","severity":"ICU/Critical Care","severity_detail":null,"comments":null,"report":5446},{"id":10231,"duration":null,"drug":{"id":9463,"name":"Oseltamivir","url":"cure-api2.ncats.io/v1/drugs/9463","rxNorm_id":null,"notes":null},"use_drug":[{"id":5985,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":10231}],"created":"2020-05-05T13:29:54.345969Z","updated":"2020-05-06T00:20:19.348697Z","dose":"oseltamivir  was  withdrawn  after  once  administration","frequency":"","route":"","severity":"ICU/Critical Care","severity_detail":null,"comments":null,"report":5446},{"id":10232,"duration":null,"drug":{"id":11329,"name":"Xuebijing","url":"cure-api2.ncats.io/v1/drugs/11329","rxNorm_id":null,"notes":null},"use_drug":[{"id":5986,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":10232}],"created":"2020-05-05T13:29:54.348997Z","updated":"2020-05-06T00:20:19.354184Z","dose":null,"frequency":"","route":"","severity":"ICU/Critical Care","severity_detail":null,"comments":null,"report":5446},{"id":10233,"duration":null,"drug":{"id":9077,"name":"Methylprednisolone","url":"cure-api2.ncats.io/v1/drugs/9077","rxNorm_id":null,"notes":null},"use_drug":[{"id":5987,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":10233}],"created":"2020-05-05T13:29:54.351914Z","updated":"2020-05-06T00:20:19.356868Z","dose":null,"frequency":"","route":"","severity":"ICU/Critical Care","severity_detail":null,"comments":null,"report":5446},{"id":10234,"duration":null,"drug":{"id":8412,"name":"Immunoglobulins, Intravenous","url":"cure-api2.ncats.io/v1/drugs/8412","rxNorm_id":null,"notes":null},"use_drug":[{"id":5988,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":10234}],"created":"2020-05-05T13:29:54.354818Z","updated":"2020-05-06T00:20:19.359586Z","dose":null,"frequency":"","route":"IV","severity":"ICU/Critical Care","severity_detail":null,"comments":null,"report":5446}],"site_of_infection":[],"specific_site":[],"how_outcome":[{"id":7159,"answer":"Imaging","answer_other":"","report":5446},{"id":7160,"answer":"PCR","answer_other":"","report":5446}],"how_diagnosis":[{"id":11810,"answer":"PCR","answer_other":"","report":5446},{"id":11908,"answer":"Imaging","answer_other":"","report":5446}],"author_username":"CURE ID Admin","resistant_drugs":[],"combo_drugs":[],"organisms":[{"id":1887,"name":"Severe acute respiratory syndrome coronavirus 2 (sars-cov-2)"}],"disease_name":"COVID-19","author_qualification":"Medical Doctor","author_affiliation":"FDA/NCATS","author_country":"United States","outcome_computed":"Deteriorated","previous_drugs":[],"comments":[],"article_language":"English","why_new_way":[{"id":3263,"answer":"There is no standard/approved therapy for this disease","answer_other":"","report":5446}],"adverse_event_outcome":[],"is_author":false,"cross_linked_diseases":[{"id":396,"name":"Pneumonia"}],"races":[],"created":"2020-04-30T01:39:35.523417Z","updated":"2020-05-05T13:29:54.305157Z","title":"Clinical remission of a critically ill patient COVID-19 patient treated by human umbilical cord mesenchymal stem cells","status":"Approved","anonymous":false,"published":true,"pubmed_id":null,"doi":"DOI：10.12074/202002.00084","article_url":"http://chinaxiv.org/abs/202002.00084v1","pub_year":2020,"published_authors":"Liang, B.","article_author_email":"huminynkm@163.com","journal":"ChinaXiv","abstract":"The COVID-19 cases increased very fast in the last two months. The mortality among critically ill  patients,  especially  the  elder  ones,  was  relatively  high.  Considering  that  most  of  the  dead  patients  were  caused  by  severe  inflammation  response,  it  is  very  urgent  to  develop  effective  therapeutic  agents  and  strategies  for  these  patients.  The  human  umbilical  cord  mesenchymal  stem  cells  (hUCMSCs)  have  shown  very  good  capability  to  modulate  immune  response  and  repair the injured tissue with good safety.","article_type":"Original","study_type":"Case Report","number_of_patients":1,"article_patient_number":"","full_text_available":true,"outcome":"Patient deteriorated","surgery":"","age":"61-70 years","sex":"Female","ethnicity":null,"country_contracted":"China","country_treated":"China","began_treatment_year":"2020","hiv":false,"asthma":false,"lung_disease":false,"diabetes_mellitus":false,"hypertension":false,"cardiovascular_disease":false,"chronic_renal_disease":false,"chronic_liver_disease":false,"immunosuppressant_drugs":false,"intellectual_disability":false,"smoker":false,"other_immunodeficiency":false,"other_comorbid":"type 2 diabetes mellitus, hypertension","pregnant":false,"unknown":false,"site_of_disease":"Lungs","clinical_syndrome":"Pneumonia","severity":"ICU/Critical Care","prev_treatment":"","unusual":"","drug_treatment_features":"","have_adverse_events":false,"adverse_events":"","when_outcome":"","follow_up_period":null,"relapse":"","reminder":false,"when_reminder":"2 weeks","additional_info":"IFN-α   inhalation   and   oseltamivir   (oseltamivir  was  withdrawn  after  once  administration),  ,  Xuebijing,  methylprednisolone, Thymosin Alpha 1 and  immunoglobulin\r\nEver on mechanical ventilation (invasive or non-invasive)?: Y\r\nAuthor defined severe?: Severe\r\nJustification for author-indicated response: \"On February 6, the serum bilirubin continuously increased, with the concentrations of DBil to 43.8μM and I-Bil to 29.5μM, indicating liver injury possibility. The concentrations of CRP (82.69mg/L), PCT (0.102ng/mL), D-Dimer (4.76 μg/mL), and ProBNP (670.2pg/mL) were very high. Although the white cell count was in normal range (8.38×109/L), but the neutrophil percentage began to increase again to a very high level (92.4%). All these results indicated that the anti- inflammatory effects of glucocorticoid, antiviral drugs and antibiotics might not work very well, and the gastrorrhagia was suspected to be caused by the side effects of glucocorticoid.\"\r\nDay in disease course that symptoms were noted to begin improving: 21\r\nDay in disease course that full resolution of symptoms was noted: NR\r\nDay in disease course that patient was discharged if admitted: NR\r\nJustification for timing of resolution: NR","previously_treated":"","flagged":false,"other_coinfections":"","disease":630,"drugs":[8412,11311,8782,9077,9197,9463,10164,11329]},{"id":5771,"regimens":[{"id":10707,"duration":{"id":4763,"approximate_duration":null,"dates_unknown":false},"drug":{"id":9463,"name":"Oseltamivir","url":"cure-api2.ncats.io/v1/drugs/9463","rxNorm_id":null,"notes":null},"use_drug":[{"id":6808,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":10707},{"id":6989,"answer":"In a novel combination with another drug","answer_other":"","regimen":10707}],"created":"2020-09-03T18:25:17.209926Z","updated":"2020-09-27T00:11:00.596143Z","dose":null,"frequency":"","route":"","severity":"ICU/Critical Care","severity_detail":null,"comments":null,"report":5771},{"id":10708,"duration":{"id":4764,"approximate_duration":null,"dates_unknown":false},"drug":{"id":10164,"name":"Ritonavir","url":"cure-api2.ncats.io/v1/drugs/10164","rxNorm_id":null,"notes":null},"use_drug":[{"id":6809,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":10708},{"id":6990,"answer":"In a novel combination with another drug","answer_other":"","regimen":10708}],"created":"2020-09-03T18:25:17.218188Z","updated":"2020-09-27T00:11:00.602722Z","dose":null,"frequency":"","route":"","severity":"ICU/Critical Care","severity_detail":null,"comments":null,"report":5771},{"id":10709,"duration":{"id":4765,"approximate_duration":null,"dates_unknown":false},"drug":{"id":8342,"name":"Hydroxychloroquine","url":"cure-api2.ncats.io/v1/drugs/8342","rxNorm_id":null,"notes":null},"use_drug":[{"id":6810,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":10709},{"id":6991,"answer":"In a novel combination with another drug","answer_other":"","regimen":10709}],"created":"2020-09-03T18:25:17.225025Z","updated":"2020-09-27T00:11:00.608343Z","dose":null,"frequency":"","route":"","severity":"ICU/Critical Care","severity_detail":null,"comments":null,"report":5771},{"id":10710,"duration":{"id":4766,"approximate_duration":null,"dates_unknown":false},"drug":{"id":11121,"name":"Vancomycin","url":"cure-api2.ncats.io/v1/drugs/11121","rxNorm_id":11124,"notes":""},"use_drug":[{"id":8293,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":10710},{"id":6992,"answer":"Other","answer_other":"Likely given for bacterial cover","regimen":10710}],"created":"2020-09-03T18:25:17.231944Z","updated":"2020-09-27T00:11:00.640441Z","dose":null,"frequency":"","route":"","severity":"ICU/Critical Care","severity_detail":null,"comments":null,"report":5771}],"site_of_infection":[],"specific_site":[],"how_outcome":[{"id":7524,"answer":"Clinical assessment","answer_other":"","report":5771}],"how_diagnosis":[{"id":12769,"answer":"Clinical assessment","answer_other":"","report":5771},{"id":12770,"answer":"Imaging","answer_other":"","report":5771}],"author_username":"Maya Younoszai","resistant_drugs":[],"combo_drugs":[],"organisms":[{"id":1887,"name":"Severe acute respiratory syndrome coronavirus 2 (sars-cov-2)"}],"disease_name":"COVID-19","author_qualification":"Nurse Practitioner","author_affiliation":"None","author_country":"","outcome_computed":"Improved","previous_drugs":[],"comments":[],"article_language":"English","why_new_way":[{"id":3673,"answer":"There is no standard/approved therapy for this disease","answer_other":"","report":5771},{"id":3674,"answer":"Co-Infection or Complex Co-morbidities","answer_other":"","report":5771}],"adverse_event_outcome":[],"is_author":false,"cross_linked_diseases":[{"id":396,"name":"Pneumonia"}],"races":[{"id":104,"answer":"White","answer_other":""}],"created":"2020-09-03T18:23:04.310796Z","updated":"2020-09-27T00:11:00.588286Z","title":"A 63-year-old man treated for coronavirus disease 2019.","status":"Approved","anonymous":false,"published":true,"pubmed_id":32231172,"doi":"10.20452/pamw.15271","article_url":"https://www.ncbi.nlm.nih.gov/pubmed/?term=32231172","pub_year":2020,"published_authors":"Sabri A\r\nSanei Taheri M\r\nMahdavi A\r\nDobranowski J","article_author_email":"jdobrano@mcmaster.ca","journal":"Polish archives of internal medicine","abstract":"A 63-year-old man presented with cough, dyspnea, and fever (38ºC). His respiratory rate was 20 breaths/min and arterial oxygen saturation was 91% on room air. Past medical history in­cluded diabetes mellitus, hyperlipidemia, and hepatitis B infection. He was admitted to the intensive care unit but not intubated.","article_type":"Original","study_type":"Case Report","number_of_patients":1,"article_patient_number":"","full_text_available":true,"outcome":"Patient was cured/recovered","surgery":"No","age":"61-70 years","sex":"Male","ethnicity":"Not Hispanic/Latino","country_contracted":"","country_treated":"","began_treatment_year":"2020","hiv":false,"asthma":false,"lung_disease":false,"diabetes_mellitus":true,"hypertension":false,"cardiovascular_disease":false,"chronic_renal_disease":false,"chronic_liver_disease":false,"immunosuppressant_drugs":false,"intellectual_disability":false,"smoker":false,"other_immunodeficiency":false,"other_comorbid":"hyperlipidemia","pregnant":false,"unknown":false,"site_of_disease":"Lungs","clinical_syndrome":"respiratory tract infection","severity":null,"prev_treatment":"","unusual":"","drug_treatment_features":"","have_adverse_events":false,"adverse_events":"","when_outcome":"At the time the treatment was completed","follow_up_period":null,"relapse":"No","reminder":false,"when_reminder":"1 week","additional_info":"","previously_treated":"","flagged":false,"other_coinfections":"Hepatitis B","disease":630,"drugs":[8342,9463,10164,11121]},{"id":6088,"regimens":[{"id":11483,"duration":{"id":5538,"approximate_duration":null,"dates_unknown":false},"drug":{"id":7165,"name":"Darunavir","url":"cure-api2.ncats.io/v1/drugs/7165","rxNorm_id":null,"notes":null},"use_drug":[{"id":8100,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":11483},{"id":8101,"answer":"In a novel combination with another drug","answer_other":"","regimen":11483}],"created":"2020-09-24T17:47:39.762480Z","updated":"2020-12-17T20:13:53.761893Z","dose":"600 mg","frequency":"BD","route":"PO","severity":"ICU/Critical Care","severity_detail":"","comments":null,"report":6088},{"id":11484,"duration":{"id":5539,"approximate_duration":null,"dates_unknown":false},"drug":{"id":10164,"name":"Ritonavir","url":"cure-api2.ncats.io/v1/drugs/10164","rxNorm_id":null,"notes":null},"use_drug":[{"id":8169,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":11484},{"id":8170,"answer":"In a novel combination with another drug","answer_other":"","regimen":11484}],"created":"2020-09-24T17:47:39.770463Z","updated":"2020-12-17T20:13:53.768445Z","dose":"100 mg","frequency":"BD","route":"PO","severity":"ICU/Critical Care","severity_detail":"","comments":null,"report":6088},{"id":11485,"duration":{"id":5540,"approximate_duration":null,"dates_unknown":false},"drug":{"id":8342,"name":"Hydroxychloroquine","url":"cure-api2.ncats.io/v1/drugs/8342","rxNorm_id":null,"notes":null},"use_drug":[{"id":8171,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":11485},{"id":8172,"answer":"In a novel combination with another drug","answer_other":"","regimen":11485}],"created":"2020-09-24T17:47:39.776501Z","updated":"2020-12-17T20:13:53.773934Z","dose":"400 mg","frequency":"OD","route":"PO","severity":"ICU/Critical Care","severity_detail":"","comments":null,"report":6088},{"id":11486,"duration":{"id":5541,"approximate_duration":null,"dates_unknown":false},"drug":{"id":11165,"name":"Favipiravir","url":"cure-api2.ncats.io/v1/drugs/11165","rxNorm_id":null,"notes":null},"use_drug":[{"id":8173,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":11486},{"id":8174,"answer":"In a novel combination with another drug","answer_other":"","regimen":11486}],"created":"2020-09-24T17:47:39.782617Z","updated":"2020-12-17T20:13:53.779733Z","dose":"loading dose of 1600 mg orally every 12 h, followed by 600 mg orally every 8 h","frequency":"TDS","route":"PO","severity":"ICU/Critical Care","severity_detail":"","comments":null,"report":6088},{"id":11487,"duration":{"id":5542,"approximate_duration":null,"dates_unknown":false},"drug":{"id":9593,"name":"Peginterferon Alfa-2A","url":"cure-api2.ncats.io/v1/drugs/9593","rxNorm_id":null,"notes":null},"use_drug":[{"id":8175,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":11487},{"id":8176,"answer":"In a novel combination with another drug","answer_other":"","regimen":11487}],"created":"2020-09-24T17:47:39.788562Z","updated":"2020-12-17T20:13:53.811309Z","dose":"180 μg","frequency":"single dose","route":"subcutaneously","severity":"ICU/Critical Care","severity_detail":null,"comments":null,"report":6088}],"site_of_infection":[],"specific_site":[],"how_outcome":[{"id":8023,"answer":"Imaging","answer_other":"","report":6088},{"id":8024,"answer":"PCR","answer_other":"","report":6088},{"id":8025,"answer":"Clinical assessment","answer_other":"","report":6088}],"how_diagnosis":[{"id":13602,"answer":"Clinical assessment","answer_other":"","report":6088},{"id":13603,"answer":"Imaging","answer_other":"","report":6088},{"id":13604,"answer":"PCR","answer_other":"","report":6088}],"author_username":"Parvesh Paul","resistant_drugs":[],"combo_drugs":[],"organisms":[{"id":1887,"name":"Severe acute respiratory syndrome coronavirus 2 (sars-cov-2)"}],"disease_name":"COVID-19","author_qualification":"Medical Doctor","author_affiliation":"Christian Medical College, Ludhiana, Punjab, India.","author_country":"India","outcome_computed":"Improved","previous_drugs":[],"comments":[],"article_language":"English","why_new_way":[{"id":4079,"answer":"There is no standard/approved therapy for this disease","answer_other":"","report":6088},{"id":4080,"answer":"Co-Infection or Complex Co-morbidities","answer_other":"","report":6088}],"adverse_event_outcome":[],"is_author":false,"cross_linked_diseases":[{"id":396,"name":"Pneumonia"},{"id":550,"name":"Respiratory Tract Infections"}],"races":[{"id":336,"answer":"White","answer_other":""}],"created":"2020-09-24T17:44:37.657208Z","updated":"2020-12-17T20:13:53.754280Z","title":"Treatment of severe pneumonia due to COVID-19 with peginterferon alfa 2a. Case 1","status":"Approved","anonymous":false,"published":true,"pubmed_id":32483527,"doi":"10.1016/j.idcr.2020.e00837","article_url":"https://pubmed.ncbi.nlm.nih.gov/32483527/","pub_year":2020,"published_authors":"El-Lababidi RM\r\nMooty M\r\nBonilla MF\r\nSalem NM","article_author_email":"Author email could not be found.","journal":"IDCases","abstract":"The outbreak of the new coronavirus disease 2019 (COVID-19) has spread rapidly worldwide. Until now, no definite effective treatment has been identified. We reported 3 patients with severe COVID-19 treated with pegylated interferon alfa 2a with satisfactory recovery. Based on these observations, randomized studies with interferons should be considered in deteriorating patients infected with COVID-19.          \r\n        Keywords:      \r\n                  Coronavirus disease 2019; Interferons; Pegylated interferon alfa 2a; SARS-CoV-2.","article_type":"Original","study_type":"Case Report","number_of_patients":3,"article_patient_number":"1","full_text_available":true,"outcome":"Patient was cured/recovered","surgery":"No","age":"31-40 years","sex":"Male","ethnicity":"Not Hispanic/Latino","country_contracted":"Italy","country_treated":"United Arab Emirates","began_treatment_year":"2020","hiv":false,"asthma":false,"lung_disease":false,"diabetes_mellitus":false,"hypertension":false,"cardiovascular_disease":false,"chronic_renal_disease":false,"chronic_liver_disease":false,"immunosuppressant_drugs":false,"intellectual_disability":false,"smoker":false,"other_immunodeficiency":false,"other_comorbid":"","pregnant":false,"unknown":false,"site_of_disease":"Lungs","clinical_syndrome":"Pneumonia","severity":null,"prev_treatment":"","unusual":"","drug_treatment_features":"","have_adverse_events":false,"adverse_events":"","when_outcome":"","follow_up_period":null,"relapse":"Unknown","reminder":false,"when_reminder":"1 week","additional_info":"A sputum culture with gram stain as well as methicillin-resistant S. aureus nasal swab were collected, and an empiric antibacterial regimen of cefepime and intravenous vancomycin was initiated to cover a possible hospital-acquired pneumonia.\r\nCefepime and vancomycin were de-escalated to amoxicillin-clavulanate when sputum culture showed growth of normal oral flora and the MRSA nasal swab was negative.\r\nFavipiravir was added to his regimen at a loading dose of 1600 mg orally every 12 h, followed by 600 mg orally every 8 h, and hydroxychloroquine was discontinued.","previously_treated":"","flagged":false,"other_coinfections":"","disease":630,"drugs":[7165,11165,8342,9593,10164]},{"id":6826,"regimens":[{"id":13847,"duration":{"id":7739,"approximate_duration":null,"dates_unknown":false},"drug":{"id":7165,"name":"Darunavir","url":"cure-api2.ncats.io/v1/drugs/7165","rxNorm_id":null,"notes":null},"use_drug":[{"id":12816,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":13847},{"id":12817,"answer":"In a novel combination with another drug","answer_other":"","regimen":13847}],"created":"2020-12-29T19:56:00.169570Z","updated":"2020-12-29T20:02:17.092564Z","dose":"","frequency":"","route":"","severity":"Inpatient","severity_detail":"","comments":null,"report":6826},{"id":13848,"duration":{"id":7740,"approximate_duration":null,"dates_unknown":false},"drug":{"id":10164,"name":"Ritonavir","url":"cure-api2.ncats.io/v1/drugs/10164","rxNorm_id":null,"notes":null},"use_drug":[{"id":12818,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":13848},{"id":12819,"answer":"In a novel combination with another drug","answer_other":"","regimen":13848}],"created":"2020-12-29T19:56:00.177380Z","updated":"2020-12-29T20:02:17.099201Z","dose":"","frequency":"","route":"","severity":"Inpatient","severity_detail":"","comments":null,"report":6826},{"id":13849,"duration":{"id":7741,"approximate_duration":null,"dates_unknown":false},"drug":{"id":11165,"name":"Favipiravir","url":"cure-api2.ncats.io/v1/drugs/11165","rxNorm_id":null,"notes":null},"use_drug":[{"id":12820,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":13849},{"id":12821,"answer":"In a novel combination with another drug","answer_other":"","regimen":13849}],"created":"2020-12-29T19:56:00.183628Z","updated":"2020-12-29T20:02:17.104679Z","dose":"","frequency":"","route":"","severity":"Inpatient","severity_detail":"","comments":null,"report":6826},{"id":13850,"duration":{"id":7742,"approximate_duration":null,"dates_unknown":false},"drug":{"id":8342,"name":"Hydroxychloroquine","url":"cure-api2.ncats.io/v1/drugs/8342","rxNorm_id":null,"notes":null},"use_drug":[{"id":12822,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":13850},{"id":12823,"answer":"In a novel combination with another drug","answer_other":"","regimen":13850}],"created":"2020-12-29T19:56:00.190387Z","updated":"2020-12-29T20:02:17.110610Z","dose":"","frequency":"","route":"","severity":"Inpatient","severity_detail":"","comments":null,"report":6826},{"id":13851,"duration":{"id":7743,"approximate_duration":null,"dates_unknown":false},"drug":{"id":6122,"name":"Azithromycin","url":"cure-api2.ncats.io/v1/drugs/6122","rxNorm_id":null,"notes":null},"use_drug":[{"id":12824,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":13851},{"id":12825,"answer":"In a novel combination with another drug","answer_other":"","regimen":13851}],"created":"2020-12-29T19:56:00.196543Z","updated":"2020-12-29T20:02:17.116258Z","dose":"","frequency":"","route":"","severity":"Inpatient","severity_detail":"","comments":null,"report":6826},{"id":13852,"duration":{"id":7744,"approximate_duration":null,"dates_unknown":false},"drug":{"id":6675,"name":"Ceftriaxone","url":"cure-api2.ncats.io/v1/drugs/6675","rxNorm_id":null,"notes":null},"use_drug":[{"id":12826,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":13852},{"id":12827,"answer":"In a novel combination with another drug","answer_other":"","regimen":13852}],"created":"2020-12-29T19:56:00.202785Z","updated":"2020-12-29T20:02:17.122076Z","dose":"","frequency":"","route":"","severity":"Inpatient","severity_detail":"","comments":null,"report":6826}],"site_of_infection":[],"specific_site":[],"how_outcome":[{"id":8975,"answer":"Clinical assessment","answer_other":"","report":6826},{"id":8976,"answer":"Imaging","answer_other":"","report":6826}],"how_diagnosis":[{"id":15435,"answer":"Clinical assessment","answer_other":"","report":6826},{"id":15436,"answer":"Imaging","answer_other":"","report":6826},{"id":15437,"answer":"PCR","answer_other":"","report":6826}],"author_username":"Kate Borkowski","resistant_drugs":[],"combo_drugs":[],"organisms":[{"id":1887,"name":"Severe acute respiratory syndrome coronavirus 2 (sars-cov-2)"}],"disease_name":"COVID-19","author_qualification":"Nurse","author_affiliation":"None","author_country":"","outcome_computed":"Improved","previous_drugs":[],"comments":[],"article_language":"English","why_new_way":[{"id":5066,"answer":"There is no standard/approved therapy for this disease","answer_other":"","report":6826}],"adverse_event_outcome":[],"is_author":false,"cross_linked_diseases":[{"id":396,"name":"Pneumonia"}],"races":[],"created":"2020-12-29T19:54:57.199710Z","updated":"2020-12-29T20:02:17.084410Z","title":"'Ring of fire' appearance in COVID-19 pneumonia.","status":"Approved","anonymous":false,"published":true,"pubmed_id":32587120,"doi":"10.1136/bcr-2020-236167","article_url":"https://pubmed.ncbi.nlm.nih.gov/32587120/","pub_year":2020,"published_authors":"Piyavisetpat N\r\nPongpirul K\r\nSukkasem W\r\nPantongrag-Brown L","article_author_email":"doctorkrit@gmail.com","journal":"BMJ case reports","abstract":"Since the beginning of the outbreak in December 2019, many radiologic findings in COVID-19 pneumonia have been described in the literature. The predominant lung finding is ground-glass opacities, some with a round morphology. A crazy-paving pattern, consolidation with or without a peripheral halo, air bronchograms, thickened interlobular septa and adjacent pleura are also reported. The abnormalities have a predilection for the peripheral and subpleural regions of the lungs and are commonly bilateral. A peribronchovascular distribution has not been common in the reports of COVID-19 pneumonia.","article_type":"Original","study_type":"Case Report","number_of_patients":1,"article_patient_number":"","full_text_available":true,"outcome":"Patient was cured/recovered","surgery":"No","age":"31-40 years","sex":"Male","ethnicity":null,"country_contracted":"Thailand","country_treated":"Thailand","began_treatment_year":"2020","hiv":false,"asthma":false,"lung_disease":false,"diabetes_mellitus":false,"hypertension":false,"cardiovascular_disease":false,"chronic_renal_disease":false,"chronic_liver_disease":false,"immunosuppressant_drugs":false,"intellectual_disability":false,"smoker":false,"other_immunodeficiency":false,"other_comorbid":"","pregnant":false,"unknown":false,"site_of_disease":"Lungs","clinical_syndrome":"Pneumonia","severity":null,"prev_treatment":"","unusual":"Chest CT performed on the seventh day of his illness revealed a ring-like opacity in the apicoposterior segment of the left upper lobe. This ring-like abnormality was a mixture of consolidation and ground-glass opacity along with the peribronchovascular bundle with wavy contour, mimicking a flame.","drug_treatment_features":"","have_adverse_events":false,"adverse_events":"","when_outcome":"After a period of follow-up","follow_up_period":"1 week after start of treatment","relapse":"No","reminder":false,"when_reminder":"1 week","additional_info":"","previously_treated":"","flagged":false,"other_coinfections":"","disease":630,"drugs":[6122,6675,7165,11165,8342,10164]}]